Press Releases from DelveInsight Business Research LLP (4751 total)
Hypertrophic Cardiomyopathy Therapeutics Market Size in the 7MM was ~USD 646 mil …
DelveInsight's "Hypertrophic Cardiomyopathy Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Hypertrophic Cardiomyopathy, historical and forecasted epidemiology as well as…
Pericarditis Treatment Market Size in 7MM is expected to grow at a decent CAGR b …
DelveInsight's "Pericarditis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pericarditis, historical and forecasted epidemiology as well as the Pericarditis…
Cardiogenic Shock Treatment Market Size in 7MM is expected to grow at a decent C …
DelveInsight's "Cardiogenic Shock Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Cardiogenic Shock, historical and forecasted epidemiology as well as…
Myocarditis Treatment Market Size in 7MM is expected to grow at a decent CAGR by …
DelveInsight's "Myocarditis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Myocarditis, historical and forecasted epidemiology as well as the Myocarditis…
Acquired Hemophilia A Pipeline 2025: Groundbreaking Clinical Advancements by 10+ …
With Acquired Hemophilia A reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Primary Axillary Hyperhidrosis Pipeline 2025: Groundbreaking Clinical Advancemen …
With Primary Axillary Hyperhidrosis reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Buerger's Disease Pipeline 2025: Groundbreaking Clinical Advancements by 3+ Glob …
With Buerger's Disease reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Mucopolysaccharidosis III Pipeline 2025: Groundbreaking Clinical Advancements by …
With Mucopolysaccharidosis III reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Hypercholesterolemia Pipeline 2025: Groundbreaking Clinical Advancements by 25+ …
With Hypercholesterolemia reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand…
Brain Metastases Pipeline 2025: Groundbreaking Clinical Advancements by 40+ Glob …
With Brain Metastases reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Non Muscle Invasive Bladder Cancer Pipeline 2025: Groundbreaking Clinical Advanc …
With Non Muscle Invasive Bladder Cancer reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there…
Malignant Ascites Pipeline 2025: Groundbreaking Clinical Advancements by 5+ Glob …
With Malignant Ascites reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Anaplastic Thyroid Cancer Pipeline 2025: Groundbreaking Clinical Advancements by …
With Anaplastic Thyroid Cancer reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Anaplastic Large Cell Lymphoma Pipeline 2025: Groundbreaking Clinical Advancemen …
With Anaplastic Large Cell Lymphoma reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is…
Bardet-Biedl Syndrome Pipeline 2025: Groundbreaking Clinical Advancements by 8+ …
With Bardet-Biedl Syndrome reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Small Fiber Neuropathy Pipeline Appears Robust With 3+ Key Pharma Companies Acti …
DelveInsight's "Small Fiber Neuropathy Pipeline Insight 2025" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Small Fiber Neuropathy pipeline landscape. It…
Bronchiectasis Pipeline Appears Robust With 15+ Key Pharma Companies Actively Wo …
DelveInsight's, "Bronchiectasis Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Bronchiectasis pipeline landscape. It covers the pipeline drug…
Uterine Sarcoma Treatment Market Size in 7MM is expected to grow at a decent CAG …
DelveInsight's "Uterine Sarcoma Market Insights, Epidemiology, and Market Forecast-2032" Report delivers an in-depth understanding of the Uterine Sarcoma, historical and forecasted epidemiology as well as…
Gastroesophageal Adenocarcinoma Treatment Market Size in 7MM is expected to grow …
DelveInsight's "Gastroesophageal Adenocarcinoma Market Insights, Epidemiology, and Market Forecast-2034" Report delivers an in-depth understanding of the Gastroesophageal Adenocarcinoma, historical and forecasted epidemiology as well as…
Severe Toxicities in Lymphoma Treatment Market Size in 7MM is expected to grow a …
DelveInsight's "Severe Toxicities in Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" Report delivers an in-depth understanding of the Severe Toxicities in Lymphoma, historical and forecasted…
Fill Finish Manufacturing Market to Witness Upsurge in Growth by 2030, Assesses …
DelveInsight's Fill Finish Manufacturing Market Insights report provides the current and forecast market analysis, individual leading Fill Finish Manufacturing Companies market shares, challenges, Fill Finish…
Multiple System Atrophy Pipeline Appears Robust With 20+ Key Pharma Companies Ac …
DelveInsight's "Multiple System Atrophy Pipeline Insight, 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Multiple System Atrophy pipeline landscape.…
Chronic Spontaneous Urticaria Pipeline Appears Robust With 20+ Key Pharma Compan …
DelveInsight's, "Chronic Spontaneous Urticaria Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Chronic Spontaneous Urticaria pipeline landscape. It…
Metastatic Breast Cancer Pipeline Appears Robust With 100+ Key Pharma Companies …
DelveInsight's, "Metastatic Breast Cancer Pipeline Insights 2025" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Metastatic Breast Cancer pipeline landscape. It…
ANCA Vasculitis Pipeline Appears Robust With 12+ Key Pharma Companies Actively W …
DelveInsight's, "ANCA Vasculitis Pipeline Insight 2025" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in ANCA Vasculitis pipeline landscape. It covers the…
Aspergillosis Pipeline Appears Robust With 20+ Key Pharma Companies Actively Wor …
DelveInsight's, "Aspergillosis Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Aspergillosis pipeline landscape. It covers the Aspergillosis pipeline…
T-Cell Prolymphocytic Leukemia Pipeline Appears Robust With 5+ Key Pharma Compan …
DelveInsight's, "T-Cell Prolymphocytic Leukemia Pipeline Insight 2025" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in T-Cell Prolymphocytic Leukemia pipeline landscape. It…
Minimal Residual Disease Pipeline Appears Robust With 8+ Key Pharma Companies Ac …
DelveInsight's, "Minimal Residual Disease Pipeline Insight 2025" report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Minimal Residual Disease pipeline landscape. It…
Microsatellite Stable Colorectal Cancer Pipeline Appears Robust With 10+ Key Pha …
DelveInsight's, "Microsatellite Stable Colorectal Cancer Pipeline Insight 2025" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Microsatellite Stable Colorectal Cancer pipeline…
Sjogren's Syndrome Pipeline Appears Robust With 15+ Key Pharma Companies Activel …
DelveInsight's, "Sjogren's Syndrome Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Sjogren's Syndrome pipeline landscape. It covers the…
Atopic Keratoconjunctivitis Pipeline Appears Robust With 10+ Key Pharma Companie …
DelveInsight's, "Atopic Keratoconjuctivitis Pipeline Insight 2025" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Atopic Keratoconjuctivitis pipeline landscape. It covers the…
Vernal Keratoconjunctivitis Pipeline Appears Robust With 5+ Key Pharma Companies …
DelveInsight's, "Vernal Keratoconjunctivitis Pipeline Insight 2025" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Vernal Keratoconjunctivitis pipeline landscape. It covers the…
Advanced Urothelial Carcinoma Pipeline Appears Robust With 20+ Key Pharma Compan …
DelveInsight's, "Advanced Urothelial Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Advanced Urothelial Carcinoma pipeline landscape. It…
Neuroendocrine Tumors Market: Epidemiology, Therapies, Companies, DelveInsight | …
Neuroendocrine Tumors therapies, such as CAM2029, CABOMETYX (cabozantinib), RYZ101 (actinium-225 DOTATATE), AlphaMedix, Paltusotine, ONC201, VMT-α-NET, Tirapazamine, CHM-2101, and others, are expected to boost the Neuroendocrine…
Post-Polycythemia Vera Myelofibrosis Pipeline 2025: Groundbreaking Clinical Adva …
With Post-Polycythemia Vera Myelofibrosis reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline 2025: Groundbreaki …
With Adeno-Associated Virus (AAV) Vectors in Gene Therapy reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain…
Metastatic Prostate Cancer Market: Epidemiology, Therapies, Companies, DelveInsi …
Metastatic Prostate Cancer therapies, such as NUBEQA (darolutamide), ERLEADA (apalutamide), MGC018 (vobramitamab duocarmazine), Bavdegalutamide (ARV-110), and others, are expected to boost the Metastatic Prostate Cancer…
Dengue Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in …
DelveInsight's, "Dengue Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Dengue pipeline landscape. It covers the Dengue pipeline…
Her2+ Non Small Cell Lung Cancer Market: Epidemiology, Therapies, Companies, Del …
Her2+ Non Small Cell Lung Cancer therapies, such as Pyrotinib, DZD9008, Mobocertinib (TAK-788), and others, are expected to boost the Her2+ Non Small Cell Lung…
Benign Breast Disease and Early Breast Cancer Market: Epidemiology, Therapies, C …
Benign Breast Disease and Early Breast Cancer therapies, such as ECHOPULSE, ProSense, and others, are expected to boost the Benign Breast Disease and Early Breast…
Glioma Market: Epidemiology, Therapies, Companies, DelveInsight | Chimerix, Sumi …
Glioma therapies, such as ONC 201, DSP-7888, AV-GBM-1, DB102, AB-218, and others, are expected to boost the Glioma Market in the upcoming years.
DelveInsight has launched…
Extensive-Stage Small Cell Lung Cancer Pipeline 2025: Groundbreaking Clinical Ad …
With Extensive-Stage Small Cell Lung Cancer reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there…
Oligometastatic Disease Market: Epidemiology, Therapies, Companies, DelveInsight …
Oligometastatic Disease emerging therapies, such as IMSA101, PNT2002 (177Lu-PNT2002), and others, are expected to boost the Oligometastatic Disease Market in the upcoming years.
DelveInsight has launched…
Metastatic renal cell carcinoma Pipeline 2025: Groundbreaking Clinical Advanceme …
With Metastatic renal cell carcinoma reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is…
Pancreatic Ductal Adenocarcinoma Pipeline 2025: Groundbreaking Clinical Advancem …
With Pancreatic Ductal Adenocarcinoma reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Relapsed/refractory acute myeloid leukemia (AML) Pipeline 2025: Groundbreaking C …
With Relapsed/refractory acute myeloid leukemia (AML) reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there…
C-MET Metastatic NSCLC Market: Epidemiology, Therapies, Companies, DelveInsight …
C-MET Metastatic NSCLC therapies, such as TABRECTA, TEPMETKO, Telisotuzumab Vedotin, REGN5093, REGN5093-M114, APL-101, MYTX-011, Glumetinib, Amivantamab and Capmatinib Combination Therapy, and others, are expected to…
Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market: …
Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) therapies, such as TAGRISSO, GILOTRIF/GIOTRIF, TARCEVA, RYBREVANT, VIZIMPRO, IRESSA, PORTRAZZA, Aumolertinib, Zipalertinib, Furmonertinib, BDTX-1535, Dato-DXd, BDTX-1535,…
Acid Sphingomyelinase Deficiency Market: Epidemiology, Therapies, Companies, Del …
Acid Sphingomyelinase Deficiency therapies, such as XENPOZYME (olipudase alfa), and others, are expected to boost the Acid Sphingomyelinase Deficiency Market in the upcoming years.
DelveInsight has…
Alpha-1 Antitrypsin Deficiency Market: Epidemiology, Therapies, Companies, Delve …
Alpha-1 Antitrypsin Deficiency therapies, such as SAR447537 (INBRX-101), WVE-006, BEAM-302, NTLA-3001, KB408, and others, are expected to boost the Alpha-1 Antitrypsin Deficiency Market in the…
Go To Page: 1 2 3 4 5 6 7 8 9 10 71 72 73 74 75 76 77 78 79 80
